Overview

A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809

Status:
Completed
Trial end date:
2007-06-20
Target enrollment:
Participant gender:
Summary
GSK598809 is being developed to facilitate overcoming an addiction to nicotine and to help people stop smoking. This study will investigate if GSK598809 is safe and tolerated in people who smoke and will also look at blood levels of GSK598809 and nicotine.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline